AIP
TNGX icon

Ameritas Investment Partners’s Tango Therapeutics TNGX Stock Holding History

Ameritas Investment Partners’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$190K Buy
9,089
+456
+5% +$6.35K 0.01% 1293
2025
Q4 		$76.5K Buy
8,633
+2,640
+44% +$22.7K ﹤0.01% 1854
2025
Q3 		$50.3K Sell
5,993
-1,837
-23% -$12.4K ﹤0.01% 2119
2025
Q2 		$40.1K Buy
7,830
+3,452
+79% +$8.54K ﹤0.01% 2330
2025
Q1 		$6K Hold
4,378
– – ﹤0.01% 2936
2024
Q4 		$13.5K Hold
4,378
– – ﹤0.01% 2808
2024
Q3 		$33.7K Hold
4,378
– – ﹤0.01% 2406
2024
Q2 		$37.6K Hold
4,378
– – ﹤0.01% 2299
2024
Q1 		$34.8K Hold
4,378
– – ﹤0.01% 2323
2023
Q4 		$43.3K Buy
4,378
+880
+25% +$7.64K ﹤0.01% 2250
2023
Q3 		$39.4K Hold
3,498
– – ﹤0.01% 2227
2023
Q2 		$11.6K Hold
3,498
– – ﹤0.01% 2852
2023
Q1 		$13.8K Hold
3,498
– – ﹤0.01% 2604
2022
Q4 		$25K Hold
3,498
– – ﹤0.01% 2469
2022
Q3 		$12K Hold
3,498
– – ﹤0.01% 2756
2022
Q2 		$15K Buy
+3,498
New +$21.2K ﹤0.01% 2698

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Ameritas Investment Partners's TNGX Position: Q1 2026 in Review

Ameritas Investment Partners increased its Tango Therapeutics (TNGX) stake by 5.3% in Q1 2026, buying an estimated $6.35K and bringing the position to 9,089 shares worth $190K. The position accounts for 0.01% of the portfolio, ranked #1293.

Ameritas Investment Partners first reported a position in TNGX in Q2 2022 and has held it in 16 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Ameritas Investment Partners held 9,089 shares of Tango Therapeutics worth $190K as of Q1 2026.
  • Ameritas Investment Partners bought 456 Tango Therapeutics shares in Q1 2026, an estimated $6.35K.
  • Tango Therapeutics made up 0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1293 holding.
  • Ameritas Investment Partners first reported a position in Tango Therapeutics in Q2 2022 and has held it in 16 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.